Skip to main content

Marks Group Wealth Management, Inc

SEC CIK
0001802473
Latest filing
Jul 27, 2026

APGE holding history

Apogee Therapeutics, Inc. in every 13F filed by Marks Group Wealth Management, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APGE overviewAll 13F holders of APGEFull Q2 2026 holdings

Shares (Q2 2026)
9,088
Value
$1.21M
% of portfolio
0.1%
Quarters held
2
Since Q1 2026
Holdings of APGE by Marks Group Wealth Management, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,088$1.21M0.1%+845+10.3%AddedHolders
Q1 20268,243$693.8K0.1%+8,243NewHolders